- Home
- PRKS vs JANX Comparison
PRKS vs JANX Comparison
Compare PRKS & JANX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- PRKS
- JANX
- Stock Information
- Founded
- PRKS 1959
- JANX 2017
- Country
- PRKS United States
- JANX United States
- Employees
- PRKS N/A
- JANX N/A
- Industry
- PRKS Biotechnology: Electromedical & Electrotherapeutic Apparatus
- JANX Biotechnology: Pharmaceutical Preparations
- Sector
- PRKS Health Care
- JANX Health Care
- Exchange
- PRKS Nasdaq
- JANX Nasdaq
- Market Cap
- PRKS 3.2B
- JANX 2.9B
- IPO Year
- PRKS 2013
- JANX 2021
- Fundamental
- Price
- PRKS $56.81
- JANX $50.31
- Analyst Decision
- PRKS Buy
- JANX Strong Buy
- Analyst Count
- PRKS 9
- JANX 11
- Target Price
- PRKS $61.78
- JANX $66.36
- AVG Volume (30 Days)
- PRKS 875.6K
- JANX 635.6K
- Earning Date
- PRKS 11-07-2024
- JANX 11-06-2024
- Dividend Yield
- PRKS N/A
- JANX N/A
- EPS Growth
- PRKS 2.23
- JANX N/A
- EPS
- PRKS 3.84
- JANX N/A
- Revenue
- PRKS $1,729,882,000.00
- JANX $13,049,000.00
- Revenue This Year
- PRKS $2.17
- JANX $66.30
- Revenue Next Year
- PRKS $1.25
- JANX N/A
- P/E Ratio
- PRKS $14.78
- JANX N/A
- Revenue Growth
- PRKS 0.10
- JANX 54.12
- 52 Week Low
- PRKS $44.72
- JANX $7.79
- 52 Week High
- PRKS $60.36
- JANX $65.60
- Technical
- Relative Strength Index (RSI)
- PRKS 57.55
- JANX 48.44
- Support Level
- PRKS $54.63
- JANX $45.95
- Resistance Level
- PRKS $57.99
- JANX $49.74
- Average True Range (ATR)
- PRKS 1.79
- JANX 2.80
- MACD
- PRKS -0.08
- JANX -0.77
- Stochastic Oscillator
- PRKS 57.82
- JANX 37.81
About PRKS United Parks & Resorts Inc. Common Stock
United Parks & Resorts Inc operates in the United States leisure industry. Its core business is the operation of theme parks and such entertainment facilities involving sea animals across the country under prominent brands such as SeaWorld, Busch Gardens, Aquatica, Discovery Cove and Sesame Place. The company generates majority of its revenue from selling admission tickets for its theme parks.
About JANX Janux Therapeutics Inc.
Janux Therapeutics Inc is a clinical-stage biopharmaceutical company developing next-generation therapeutics based on proprietary tumor activated T Cell Engager platform technology to treat patients suffering from cancer.